Explore Our Areas

Latest News

Menarini Group Shares NEXPOVIO® (selinexor) Subgroup Data from BOSTON trial at the European Hematology Association Congress, Highlighting Clinical Potential in Relapsed/Refractory Multiple Myeloma

FLORENCE (Italy), June 8, 2023 – The Menarini Group (“Menarini”), a leading Italian pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc....

Menarini Group Shares New Analysis from EMERALD Clinical Study of ORSERDU® (Elacestrant) in Metastatic Breast Cancer at ASCO 2023

FLORENCE (Italy) and New York, NY, May 26, 2023 – The Menarini Group (“Menarini”), a leading Italian pharmaceutical and diagnostics company, and Stemline Therapeutics...

Botticelli, the inquietude and the beauty

Successful artist, sensitive interpreter of the culture of his time and author of extraordinarily relevant works, Sandro Botticelli was a master of beauty.  With his...

Search Menarini in the world

v

Etiam commodo dui eget wisi. Donec iaculis gravida nulla. Donec quis nibh at felis congue commodo. Etiam bibendum elit eget erat.

Use the key combination "ctrl" + "mouse wheel" or the "+" and "-" buttons at the bottom right to browse the map



menarini for people

Discover our responsibility projects to stand close to people

read more

Follow our blog

Discover our stories from all over the world

Read More

fondazione internazionale menarini

a meeting point for all friends with common ideals towards the progress of sciences for the benefit of mankind.

sergio gorini, foundation’s first president

read more